Phibro Animal Health Corp (NASDAQ:PAHC) announced a quarterly dividend on Monday, November 4th, Zacks reports. Shareholders of record on Wednesday, November 27th will be given a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 annualized dividend and a yield of 1.98%. The ex-dividend date is Tuesday, November 26th.
PAHC stock opened at $24.26 on Friday. The stock has a market capitalization of $988.27 million, a P/E ratio of 18.51, a P/E/G ratio of 6.93 and a beta of 0.87. The company has a debt-to-equity ratio of 1.84, a current ratio of 3.21 and a quick ratio of 1.77. Phibro Animal Health has a 1-year low of $20.00 and a 1-year high of $36.98. The business has a fifty day moving average price of $22.87 and a 200-day moving average price of $26.55.
Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.05). Phibro Animal Health had a net margin of 4.99% and a return on equity of 25.52%. The company had revenue of $190.00 million for the quarter, compared to the consensus estimate of $199.22 million. During the same period in the prior year, the firm posted $0.39 EPS. The business’s revenue for the quarter was down 5.0% on a year-over-year basis. As a group, analysts anticipate that Phibro Animal Health will post 1.1 earnings per share for the current year.
A number of equities analysts have recently weighed in on PAHC shares. Bank of America dropped their price objective on Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating for the company in a research note on Thursday, August 29th. Credit Suisse Group reissued a “neutral” rating and set a $25.00 price target (down from $31.00) on shares of Phibro Animal Health in a research note on Wednesday, August 28th. BidaskClub raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Morgan Stanley raised Phibro Animal Health from an “underweight” rating to an “equal” rating and increased their price target for the company from $21.00 to $30.00 in a research note on Thursday, September 5th. They noted that the move was a valuation call. Finally, Barclays dropped their price target on Phibro Animal Health from $25.00 to $18.00 and set an “underweight” rating for the company in a research note on Thursday, August 29th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Phibro Animal Health currently has an average rating of “Hold” and an average target price of $26.60.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
See Also: Short Selling
Receive News & Ratings for Phibro Animal Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phibro Animal Health and related companies with MarketBeat.com’s FREE daily email newsletter.